CardiAQ Valve Technologies Secures $37,300,000 Series B Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b73d90da-e4b6-4d86-b5ab-cf0644575a00&Preview=1 -
Date
11/29/2012 -
Company Name
CardiAQ Valve Technologies -
Mailing Address
2 Jenner Irvine, CA 92618 -
Company Description
CardiAQ Valve Technologies (CVT), a privately held company founded by heart surgeon Dr. Arshad Quadri, is developing innovative approaches to heart valve replacement and is initially focused on percutaneous mitral valve replacement (PMVR). -
Website
http://www.cardiaq.com -
Transaction Type
Venture Equity -
Transaction Amount
$37,300,000 -
Transaction Round
Series B -
Proceeds Purposes
The funding, which incorporates conversion of a 2011 bridge financing, will be used to further validate the Company’s TMVI technology and is expected to carry the Company through its feasibility and CE mark clinical trials. -
M&A Terms
-
Venture Investor
OrbiMed Advisors -
Venture Investor
OrbiMed Advisors -
Venture Investor
Versant Ventures -
Venture Investor
Advent Healthcare Ventures
